Elucidating the Inhibitory Effect of Resveratrol and Its Structural Analogs on Selected Nucleotide-Related Enzymes

Biomolecules. 2020 Aug 22;10(9):1223. doi: 10.3390/biom10091223.

Abstract

Resveratrol, the most widely studied natural phytochemical, has been shown to interact with different target proteins. Previous studies show that resveratrol binds and inhibits DNA polymerases and some other enzymes; however, the binding and functioning mechanisms remain unknown. The elucidated knowledge of inhibitory mechanisms of resveratrol will assist us in new drug discovery. We utilized molecular docking and molecular dynamics (MD) simulation to reveal how resveratrol and structurally similar compounds bind to various nucleotide-dependent enzymes, specifically, DNA polymerases, HIV-1 reverse transcriptase, and ribonucleotide reductase. The results show that resveratrol and its analogs exert their inhibitory effects by competing with the substrate dNTPs in these enzymes and blocking elongation of chain polymerization. In addition, the results imply that resveratrol binds to a variety of other ATP-/NTP-binding proteins.

Keywords: inhibition mechanism; molecular docking; molecular dynamics simulation; nucleotide-related enzymes; resveratrol.

MeSH terms

  • Binding, Competitive
  • Catalytic Domain
  • DNA Polymerase I / antagonists & inhibitors
  • DNA Polymerase I / chemistry
  • DNA Polymerase III / antagonists & inhibitors
  • DNA Polymerase III / chemistry
  • Drug Discovery
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacology*
  • HIV Reverse Transcriptase / antagonists & inhibitors
  • HIV Reverse Transcriptase / chemistry
  • Humans
  • Hydrogen Bonding
  • In Vitro Techniques
  • Ligands
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Molecular Structure
  • Protein Conformation
  • Resveratrol / analogs & derivatives*
  • Resveratrol / chemistry
  • Resveratrol / pharmacology
  • Ribonucleotide Reductases / antagonists & inhibitors
  • Ribonucleotide Reductases / chemistry
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • Ligands
  • Ribonucleotide Reductases
  • reverse transcriptase, Human immunodeficiency virus 1
  • HIV Reverse Transcriptase
  • DNA Polymerase I
  • DNA Polymerase III
  • Resveratrol